Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.

CEO

Anshul Thakral

Employees

14000

Country

United States

Listings

0 Comments

Share your thoughts

FAQ

What is Fortrea stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Fortrea stocks are traded under the ticker FTRE V.

When is the next Fortrea earnings date?▼

Fortrea is going to release the next earnings report on November 05, 2026.

What were Fortrea earnings last quarter?▼

FTRE V earnings for the last quarter are 0.23 USD per share, whereas the estimation was 0.18 USD resulting in a +27.47% surprise. The estimated earnings for the next quarter are N/A USD per share.

What is Fortrea revenue for the last year?▼

Fortrea revenue for the last year amounts to 2.72B USD.

What is Fortrea net income for the last year?▼

FTRE V net income for the last year is -986.2M USD.

How many employees does Fortrea have?▼

As of September 27, 2026, the company has 14,000 employees.

In which sector is Fortrea located?▼

Fortrea operates in the Health & Wellness sector.

When did Fortrea complete a stock split?▼

Fortrea has not had any recent stock splits.

Where is Fortrea headquartered?▼

Fortrea is headquartered in DURHAM, United States.